Logo image
Multidrug‐resistant tuberculosis during pregnancy and adverse birth outcomes: A systematic review and meta‐analysis
Journal article   Peer reviewed

Multidrug‐resistant tuberculosis during pregnancy and adverse birth outcomes: A systematic review and meta‐analysis

K.A. Alene, A. Jegnie and A.A. Adane
BJOG: An International Journal of Obstetrics & Gynaecology, Vol.128(7), pp.1125-1133
2021
url
Link to Published Version *Subscription may be requiredView

Abstract

Background Multidrug‐resistant tuberculosis (MDR‐TB) is a major global public health concern. However, there is a dearth of literature on whether MDR‐TB and its medications impact maternal and perinatal outcomes, and when such evidence exists the findings are conflicting. Objectives This systematic review and meta‐analysis aimed to examine the impact of MDR‐TB and its medications during pregnancy on maternal and perinatal outcomes. Search strategy PubMed, Scopus and Web of Science databases were searched from earliest to February 2020. Selection criteria Records were screened based on pre‐defined selection criteria and assessed for quality by two independent reviewers. Data collection and analysis A meta‐analysis was performed using the random effects model to calculate pooled prevalence for each outcome. Main results Of the 72 records identified, 12 were included in the systematic review and meta‐analysis, consisting of 174 pregnant women with MDR‐TB and 110 adverse outcomes. Maternal death, pregnancy loss, preterm birth and low birthweight were the most common maternal and perinatal adverse outcomes reported in the studies. The overall pooled prevalence was 7.5% (95% CI 3.2–12.8) for maternal death, 10.6% (95% CI 6.0–16.3) for pregnancy loss, 12.9% (95% CI 0.0–38.0) for preterm birth and 23.7% (95% CI 17.0–31.0) for low birthweight. Conclusions The findings suggest that MDR‐TB is associated with a high risk of adverse maternal and perinatal outcomes, but these should be interpreted cautiously because the evidence is largely preliminary. Adequately powered prospective cohort studies are urgently required to corroborate these findings. Tweetable abstract Multidrug‐resistant tuberculosis may increase the risk of adverse maternal and perinatal outcomes.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.194 Tuberculosis & Leprosy
1.194.273 TB Diagnostics & Treatment
Web Of Science research areas
Obstetrics & Gynecology
ESI research areas
Clinical Medicine
Logo image